0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Editorials |

Adult Immunizations 1994

Task Force On Adult Immunization
[+] Article and Author Information

Through grants received from SmithKline Beecham Pharmaceuticals, Connaught Laboratories, Lederle-Praxis Biologicals, and Merck and Company, the American College of Physicians could provide a large portion of its membership with complimentary copies of the Guide for Adult Immunization. Recipients of the Guide included active members in internal medicine and related subspecialties in the United States, Canada, and Mexico. If you did not receive a copy of the Guide, would like to purchase additional copies, or are not a member of the College and would like to purchase a copy, please call ACP Customer Service at 1-800-523-1546, extension 2600.—The Editor


American College of Physicians: Pierce Gardner, MD, Chair; Marie Griffin, MD, MPH; Peter Gross, MD; F. Marc LaForce, MD. Infectious Diseases Society of America: William Schaffner, MD, and Theodore Eickhoff, MD. Centers for Disease Control and Prevention: Raymond Strikas, MD.


Copyright ©2004 by the American College of Physicians


Ann Intern Med. 1994;121(7):540-541. doi:10.7326/0003-4819-121-7-199410010-00012
Text Size: A A A

An estimated 50 000 to 70 000 deaths from invasive pneumococcal disease, influenza, or hepatitis B infection occur yearly among adults in the United States. Annual mortality rates from infections potentially preventable by adult vaccines exceed those from automobile crashes or the acquired immunodeficiency syndrome. Well-supported and well-organized pediatric immunization programs have reduced the overall burden of preventable infections in children to new worldwide lows. In contrast, the current use of vaccines in targeted adult groups is only 40% for influenza, 20% for pneumococcal disease, and 10% for hepatitis B infection [1]. Hepatitis B infection bears the dubious distinction of being the only disease with an incidence that increased during the decade after a highly effective vaccine was introduced.

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)